Publications by authors named "E Daci"

Claim this Profile
E
Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in "Real-World" Management of Type 2 Diabetes Mellitus: The G-FORCE Study.
Luc Van Gaal, Michel P Hermans, Evis Daci, Kris Denhaerynck, Lut De Meester

Diabetes Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study).
Michel Hermans, Luc Van Gaal, Ingrid Rézette, Evis Daci, Karen MacDonald

Prim Care Diabetes· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and tolerability of second-line therapy with vildagliptin versus other oral agents in type 2 diabetes (EDGE): post-hoc subanalysis of the Belgian data.
J Hoste, E Daci, C Mathieu

Acta Clin Belg· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission over 3 years in patients with Paget disease of bone treated with a single intravenous infusion of 5 mg zoledronic acid.
Jean-Pierre Devogelaer, Piet Geusens, Evis Daci, Evelien Gielen, Kris Denhaerynck

Calcif Tissue Int· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study).
Sandra Swimberghe, Pierre-Dominique Ghislain, Evis Daci, Katrien Allewaert, Kris Denhaerynck

Ann Dermatol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis